Last edition
News about Global Pharma
Clario, a provider of endpoint data solutions to the clinical trial industry, announced they have acquired NeuroRx, a company in imaging analysis with expertise in multiple sclerosis.
Global Pharma | 18/03/2025 | By Manvi | 283
Chance Pharma Receives New Funding to Develop Innovative Inhalation Therapies
Chance Pharma operates state-of-the-art production facilities compliant with FDA and EMA quality standards, underscoring its strong capabilities in both R&D and manufacturing.
Global Pharma | 18/03/2025 | By Aishwarya | 223
AstraZeneca Signs License Deal with Alteogen for ALT-B4
Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialise subcutaneous formulations of several oncology assets.
Global Pharma | 18/03/2025 | By Aishwarya | 535
Curia Plans Expansion to Global Network of Sterile Fill-Finish Sites
Curia’s sterile fill-finish facility in Glasgow will add an integrated, isolator-based vial filling line and lyophilizer suitable for a broad range of drug product including highly potent capabilities, more than doubling current GMP batch size.
Global Pharma | 18/03/2025 | By Aishwarya | 650
Lupin Secures Tentative Approval from US FDA for Amifampridine Tablets
Lupin Ltd. has received tentative US FDA approval for its Amifampridine Tablets, 10 mg, a generic version of Firdapse, for treating Lambert-Eaton myasthenic syndrome.
Global Pharma | 17/03/2025 | By Manvi | 566
Avanos Medical Appoints David Pacitti as its New Chief Executive Officer
Avanos Medical, Inc. announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.
Global Pharma | 17/03/2025 | By Manvi | 362
iOncologi Acquires TargImmune Therapeutics to Expand Immunotherapy Pipeline
As part of the transaction, iOncologi, Inc. and TargImmune Therapeutics executed a share purchase agreement, resulting in iOncologi acquiring at least 99 percent of TargImmune's shares, warrants, and options.
Global Pharma | 17/03/2025 | By Aishwarya | 244
Neuraceq (Florbetaben 18F) to be Available in Hong Kong by March 2025
Life Molecular Imaging (LMI) and St. Teresa's Hospital has announced that Florbetaben (18F) Injection (brand name: Neuraceq) will be available in Hong Kong from St. Teresa's Hospital by March 2025.
Global Pharma | 15/03/2025 | By Manvi | 223
Zydus Secures USFDA Approval for Methenamine Hippurate Tablets USP, 1 Gram
Zydus Lifesciences has received USFDA approval to manufacture Methenamine Hippurate Tablets USP, 1 gram, for the long-term treatment of recurrent urinary tract infections.
Global Pharma | 15/03/2025 | By Manvi | 530
Azurity Pharmaceuticals Announces Acquisition of Covis Pharma
By combining expertise and resources, Azurity strengthens its ability to deliver medicines to overlooked patients on a global scale.
Global Pharma | 15/03/2025 | By Aishwarya | 491
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy